文献速递肝病

自身免疫介导性肝病中的细胞相互作用

Cellular interactions in self-directed immune-mediated liver diseases.
PubMed 文献 · J Hepatol · 2025-01-08

本文综述淋巴细胞向肝脏的募集、迁移与滞留机制,涉及趋化因子、黏附分子及与其他肝内细胞的交互;这些相互作用紊乱与自我识别失败可驱动多种自身免疫性肝病,并描述了免疫检查点抑制剂诱导的肝损伤及新兴免疫治疗策略。

要点

  • 淋巴细胞进入肝脏依赖特定趋化因子受体与黏附分子,其定位亦受这些信号调控。
  • 细胞相互作用异常与自我识别失败是自身免疫性肝病发生的关键环节。
  • 新兴免疫治疗包括调节性T细胞、抗细胞因子/趋化因子、白细胞介素-2及共抑制分子干预。

核心结论

  • 淋巴细胞迁移与肝内细胞交互紊乱及自我识别失败可驱动多种自身免疫性肝病,新兴免疫疗法可能用于其治疗。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 淋巴细胞需穿越复杂路径到达肝脏,细胞因子、趋化因子及其他可溶性因子引导其与肝内免疫细胞、肝细胞及胆管上皮细胞进一步交互。
  • 特定趋化因子受体与黏附分子驱动淋巴细胞向肝脏的募集、迁移和滞留,并决定其在肝内的定位。
  • 自身免疫性肝炎中免疫细胞进入肝细胞(伸入运动)以及原发性胆汁性胆管炎中进入胆管上皮细胞(上皮内淋巴细胞)是自身免疫性肝病的典型特征。
  • 本文还描述了免疫检查点诱导的肝损伤。

关键数值与推荐

  • 文中汇总的标准与数值原文未报告。

临床怎么用

  • 作者描述了新兴免疫治疗包括调节性T细胞、抗细胞因子与抗趋化因子治疗、细胞因子补充(如白细胞介素-2)以及共抑制分子调控(包括T细胞衔接器),并讨论了其在自身免疫性肝病治疗中的潜在应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The lymphocyte population must traverse a complex path throughout their journey to the liver. The signals which these cells must detect, including cytokines, chemokines and other soluble factors, steer their course towards further crosstalk with other hepatic immune cells, hepatocytes and biliary epithelial cells. A series of specific chemokine receptors and adhesion molecules drive not only the recruitment, migration, and retention of these cells within the liver, but also their localisation. Perturbation of these interactions and failure of self-recognition drive the development of several autoimmune liver diseases. We also describe check point-induced liver injury. Immune cell internalisation into hepatocytes (emperipolesis) in autoimmune hepatitis and into biliary epithelial cells (intra-epithelial lymphocyte) in primary biliary cholangitis are typical features in autoimmune liver diseases. Finally, we describe emerging immune-based therapies, including regulatory T cell, anti-cytokine and anti-chemokine therapies, cytokine supplementation (e.g. interleukin-2), as well as co-inhibitory molecule manipulation, including T-cell engagers, and discuss their potential application in the treatment of autoimmune liver diseases.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Bozward AG, Davies SP, Morris SM, et al. Cellular interactions in self-directed immune-mediated liver diseases. J Hepatol. 2025. PMID: 39793614. doi:10.1016/j.jhep.2025.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。